Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.39 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.38 |
| ▸ | SMPD1 | P17405 | 4/20 | 0.37 |
| ▸ | TP53 | P04637 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | LTA4H | P09960 | 1/20 | 0.35 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.34 |
| ▸ | KDR | P35968 | 4/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18649880 | 0.98 | MEN1 (0.62) | MEN1ALDH1A1KMT2ATBXAS1LTB4R | |
| SCHEMBL10950345 | 0.98 | MEN1 (0.62) | MEN1ALDH1A1KMT2ATBXAS1LTB4R | |
| SCHEMBL20915528 | 0.98 | MEN1 (0.62) | MEN1ALDH1A1KMT2ATBXAS1LTB4R | |
| SCHEMBL20915274 | 0.98 | MEN1 (0.62) | MEN1ALDH1A1KMT2ATBXAS1LTB4R | |
| SCHEMBL20936607 | 0.98 | MEN1 (0.62) | MEN1ALDH1A1KMT2ATBXAS1LTB4R | |
| SCHEMBL20915328 | 0.98 | MEN1 (0.62) | MEN1ALDH1A1KMT2ATBXAS1LTB4R | |
| SCHEMBL18672829 | 0.98 | MEN1 (0.62) | MEN1ALDH1A1KMT2ATBXAS1LTB4R | |
| SCHEMBL20936481 | 0.98 | MEN1 (0.62) | MEN1ALDH1A1KMT2ATBXAS1LTB4R | |
| SCHEMBL20915262 | 0.98 | MEN1 (0.62) | MEN1ALDH1A1KMT2ATBXAS1LTB4R | |
| SCHEMBL940260 | 0.98 | MEN1 (0.62) | MEN1ALDH1A1KMT2ATBXAS1LTB4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116875259-A | Moisture-cured polyurethane soft hot melt adhesive and preparation method thereof | 东莞聚力创新材料科技有限公司 | 2023-10-13 | — | — | CN | claimed |
| US-20230128348-A1 | TREATMENT OF HYPERINFLAMMATORY SYNDROME | Remicine IP B.V. (NL) | 2023-04-27 | — | — | US | claimed |
| EP-4125843-A1 | TREATMENT OF HYPERINFLAMMATORY SYNDROME | Nomoreitis B.V. (BE) | 2023-02-08 | — | — | EP | claimed |
| CN-115605194-A | Treatment of excessive inflammatory syndrome | 诺莫雷蒂斯私人有限公司（BE） | 2023-01-13 | — | — | CN | claimed |
| WO-2021201680-A1 | TREATMENT OF HYPERINFLAMMATORY SYNDROME | HASAN DJOHAN (BE) | 2021-10-07 | — | — | WO | claimed |
| EP-3386954-B1 | DIMERIC CONTRAST AGENTS | BRACCO IMAGING SPA (IT) | 2020-12-02 | — | — | EP | claimed |
| US-9691951-B2 | Curable silicone composition, and optical semiconductor device | DOW CORNING TORAY CO., LTD. (JP) | 2017-06-27 | — | — | US | claimed |
| EP-3059768-A1 | CURABLE SILICONE COMPOSITION, AND OPTICAL SEMICONDUCTOR DEVICE | Dow Corning Toray Co., Ltd. (JP) | 2016-08-24 | — | — | EP | claimed |
| US-20160233395-A1 | Curable Silicone Composition, And Optical Semiconductor Device | DOW TORAY CO., LTD. (JP) | 2016-08-11 | — | — | US | claimed |
| US-8530506-B2 | Process for production of biphenyl derivative | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2013-09-10 | — | — | US | claimed |
| US-5767270-A | PROTECTING EXOCYCLIC AMINO GROUPS | ISIS PHARMACEUTICALS, INC. (US) | 1998-06-16 | — | — | US | claimed |
| EP-0455423-B1 | Ortho-lithiation process for the synthesis of 2-substituted 1-(tetrazol-5-yl) benzenes | MERCK & CO INC (US) | 1996-12-18 | — | — | EP | claimed |
| EP-0455423-A2 | Ortho-lithiation process for the synthesis of 2-substituted 1-(tetrazol-5-yl) benzenes | MERCK & CO. INC. (US) | 1991-11-06 | — | — | EP | claimed |
| US-5039814-A | Chemical intermediates for angiotensin antagonist | MERCK & CO., INC. (US) | 1991-08-13 | — | — | US | claimed |
| US-4814112-A | Single-stage process for preparing mixed-substituted 1,2-diacyl-sn-clycero-3-phosphocholines | CL PHARMA AKTIENGESELLSCHAFT (AT) | 1989-03-21 | — | — | US | claimed |
| EP-0267565-A1 | One-step process for preparing mixed substituted 1,2-diacyl-sn-glycero-3-phosphocholines | Hafslund Nycomed Pharma Aktiengesellschaft (AT) | 1988-05-18 | — | — | EP | claimed |
| EP-0116121-B1 | PROCESS FOR THE PHOTOPOLYMERIZATION OF VINYL COMPOUNDS AND PHOTOPOLYMERIZED MATERIAL | Kulzer & Co. GmbH (DE) | 1986-10-22 | — | — | EP | claimed |
| US-4522694-A | WITH PHOTOINITIATORS COMPRISING PHOTOSENSITIZERS AND REDUCING AGENTS | KULZER & CO. GMBH (DE) | 1985-06-11 | — | — | US | claimed |
| EP-0116121-A1 | Process for the photopolymerization of vinyl compounds and photopolymerized material | Kulzer & Co. GmbH (DE) | 1984-08-22 | — | — | EP | claimed |
| US-4250252-A | A DEVELOPMENT-INHIBITOR-RELEASING COMPOUND COMPRISING A 5-(SULFOAMIDO-1-INDANONE-2-YL)THIO-TETRAZOLE | AGFA-GEVAERT, A.G. (DE) | 1981-02-10 | — | — | US | claimed |